Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1506 | Human NDE1 Protein (AC1506) | 5 µg | inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
| ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
| ACPP-1611 | Human ICA69 Protein (AC1611) | 100 µg | inquiry |
| ACPP-1189 | PDE6C Blocking Peptide (AC1189) | 250 µg | inquiry |
| ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
| ACPP-1087 | Recombinant Human IL-6 Protein (Fc Chimera 6xHis Tag) (AC1087) | 50 µg | inquiry |
| ACPP-1605 | Human PNMT Protein (AC1605) | 5 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.